Clinical Features, Imaging, Laboratory Result, and Severity of COVID-19 Patients in Referral Hospital
DOI:
https://doi.org/10.3889/oamjms.2023.10664Keywords:
COVID-19, limited resources, prognosticAbstract
BACKGROUND: COVID-19 pandemic became a global health problem due to the high number of cases and no specific treatment. Furthermore, the diagnosis was difficult due to limited publication data and diagnostic tests.
AIM: The aim of this study was to determine the demographics, clinical features, laboratory results, radiological results, and factors related to the severity of COVID-19 at a referral hospital.
METHODS: A descriptive analytic study of confirmed COVID-19 patients was conducted during March–October 2020. Data were collected from the medical records to determine the patient demographics, clinical symptoms, comorbidities, laboratory, chest X-ray, and first illness severity at 24 h of treatment.
RESULTS: There were 79 (59%) male and 55 (41%) female patients during the study. The clinical symptoms were fever 103 (77%), cough 100 (75%), shortness of breath 88 (66%), comorbidities of diabetes mellitus 18 (13%), hypertension 24 (18%), and heart disease 20 (15%). The patient’s laboratory profiles were lymphopenia 85 (63%) and increased C-reactive protein 82 (61%). The radiology imaging of the patients was mostly atypical of COVID-19. Factors that influence the severity of COVID-19 are age, comorbid diabetes, and hypertension
CONCLUSION: Most cases with severe symptoms are old age, a history of comorbid diabetes mellitus and heart disease, and abnormal laboratory results.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Parasher A. COVID-19 : Current understanding of its pathophysiology, clinical presentation and treatment. Postgr Med J. 2020;97(1147):312-20. https://doi.org/10.1136/postgradmedj-2020-138577 PMid:32978337 DOI: https://doi.org/10.1136/postgradmedj-2020-138577
World Health Organization. Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data-WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Geneva: World Health Organization; 2020. p. 2.
Rahman R. Southeast Asia Covid-19 Tracker. United States: Center for Strategic and International Studies; 2021. p. 1-35.
Hafiz M, Icksan AG, Harlivasar AD, Andarini S, Susanti F, Yuliana ME. Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia. Germs. 2021;11(1):32-8. https://doi.org/10.18683/germs.2021.1238 PMid:33898339 DOI: https://doi.org/10.18683/germs.2021.1238
Dong Y, Qiulan C, Zhe W, Ning C, Mantong Z. Epidemiological characteristics of imported cases of COVID-19 from Association of Southeast Asian Nations countries to China. Dis Surveill. 2021;36(6):561-5. https://doi.org/10.3784/jbjc202105120259
Zhu M, Kleepbua J, Guan Z, Chew SP, Tan JW, Shen J, et al. Early spatiotemporal patterns and population characteristics of the COVID-19 pandemic in Southeast Asia. Healthcare (Basel). 2021;9(9):1220. https://doi.org/10.3390/healthcare9091220 PMid:34574997 DOI: https://doi.org/10.3390/healthcare9091220
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81. https://doi.org/10.1001/jama.2020.5394 PMid:32250385 DOI: https://doi.org/10.1001/jama.2020.4031
Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):2195-8. https://doi.org/10.1001/jama.2020.7202 PMid:32329797 DOI: https://doi.org/10.1001/jama.2020.7202
Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia : A hospital-based retrospective cohort study. Lancet Reg Health West Pac.
;9:100108. https://doi.org/10.1016/j.lanwpc.2021.100108 PMid:33681830 DOI: https://doi.org/10.1016/j.lanwpc.2021.100108
Hikmawati I, Setiyabudi R. Epidemiology of COVID-19 in Indonesia : Common source and propagated source as a cause for outbreaks. J Infect Dev Ctries 2020;15:646-52. https://doi.org/10.3855/jidc.14240 DOI: https://doi.org/10.3855/jidc.14240
MurrayMF,KennyEE,RitchieMD,RaderDJ,BaleAE,GiovanniMA, et al. COVID-19 outcomes and the human genome. Genet Med. 2020;22(7):1175-7. https://doi.org/10.1038/s41436-020-0832-3 PMid:32393819 DOI: https://doi.org/10.1038/s41436-020-0832-3
Song Y, Ge Z, Cui S, Di Tian, Wan G. COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: A prospective, comparative cohort study. Microbiol Spectr. 2021;9(1):e00273-21. https://doi.org/10.1128/Spectrum.00273-21 PMid:34346755 DOI: https://doi.org/10.1101/2021.05.04.21256655
Dao TL, Hoang VT, Nguyen NN, Delerce J, Chaudet H, Levasseur A, et al. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021;27(10):1516.e1-6. https://doi.org/10.1016/j.cmi.2021.05.029 PMid:34044152 DOI: https://doi.org/10.1016/j.cmi.2021.05.029
Saxena S, Manchanda V, Sagar T, Nagi N, Siddiqui O, Yadav A, et al. Clinical characteristic and epidemiological features of SARS CoV-2 disease patients from a COVID-19 designated hospital in New Delhi. J Med Virol. 2021;93:2487-92. https://doi.org/10.1002/jmv.26777 PMid:33410174 DOI: https://doi.org/10.1002/jmv.26777
Wang C, Wang Z, Wang G, Lau JY, Zhang K, Li W. COVID-19 in early 2021: Current status and looking forward. Signal Transduct Target Ther. 2021;6(1):114. https://doi.org/10.1038/s41392-021-00527-1 PMid:33686059 DOI: https://doi.org/10.1038/s41392-021-00527-1
Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and clinical characteristics of COVID-19. Arch Iran Med. 2020;23(4):268-71. https://doi.org/10.34172/aim.2020.09 PMid:32271601 DOI: https://doi.org/10.34172/aim.2020.09
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HH, et al. Neutrophil- to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):6-12. https://doi.org/10.1016/j.jinf.2020.04.002 PMid:32283162 DOI: https://doi.org/10.1016/j.jinf.2020.04.002
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. https://doi.org/10.1007/s00392-020-01626-9 PMid:32161990 DOI: https://doi.org/10.1007/s00392-020-01626-9
Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15-27. https://doi.org/10.1159/000512007 PMid:33049751 DOI: https://doi.org/10.1159/000512007
Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, et al. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 2020;323(23):2425-7. https://doi.org/10.1001/jama.2020.8279 PMid:32421144 DOI: https://doi.org/10.1001/jama.2020.8707
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):303-10. https://doi.org/10.1016/j.dsx.2020.04.004 PMid:32298981 DOI: https://doi.org/10.1016/j.dsx.2020.04.004
Moroni C, Cozzi D, Albanesi M, Cavigli E, Bindi A, Luvarà S,
et al. Chest X-ray in the emergency department during COVID-19 pandemic descending phase in Italy: Correlation with patients’ outcome. Radiol Med. 2021;126(5):661-8. https://doi.org/10.1007/s11547-020-01327-3 PMid:33394364 DOI: https://doi.org/10.1007/s11547-020-01327-3
Cohen JP, Dao L, Roth K, Morrison P, Bengio Y, Abbasi AF, et al. Predicting COVID-19 pneumonia severity on chest X-ray with deep learning. Cureus. 2020;12(7):e9448. https://doi.org/10.7759/cureus.9448 PMid:32864270 DOI: https://doi.org/10.7759/cureus.9448
Kong W, Prachi P. Chest imaging appearance of COVID-19 infection. Radiol Cardiothorac Imaging. 2020;2(1):e20028. https://doi.org/10.1148/ryct.2020200028 PMid:33778544 DOI: https://doi.org/10.1148/ryct.2020200028
De Farias LD, Fonseca IE, Strabelli DG, Loureiro BM, Neves YC, Rodrigues TP, et al. Imaging findings in COVID-19 pneumonia. Clinics (Sao Paulo). 2020;75:e2027. https://doi.org/10.6061/clinics/2020/e2027 PMid:32578826 DOI: https://doi.org/10.6061/clinics/2020/e2027
Guan WJ, Ni Z, Hu Y, Liang W. Clinical characteristics of 2019 novel coronavirus infection in China. ???. 2020;31:257-61. DOI: https://doi.org/10.1101/2020.02.06.20020974
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA J Am Med Assoc. 2020;323(1):1061-9. https://doi.org/10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585
Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol. 2021;99:107995. https://doi.org/10.1016/j.intimp.2021.107995 PMid:34304001 DOI: https://doi.org/10.1016/j.intimp.2021.107995
Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475-82. https://doi.org/10.1016/j.cca.2020.08.019 PMid:32798514 DOI: https://doi.org/10.1016/j.cca.2020.08.019
Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Baßler K, Schultze JL, et al. Neutrophils in COVID-19. Front Immunol. 2021;12:652470. https://doi.org/10.3389/fimmu.2021.652470 PMid:33841435 DOI: https://doi.org/10.3389/fimmu.2021.652470
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Bekti Safarini, Mohamad Arif, Danis Pertiwi, Santika Puji Rahayu Wijaya, Suryani Yuliyanti (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0